Apple Inc. (AAPL): UBS sees iPhone 18 Pro wait times as broadly flat year on year outside China, while retaining a Neutral rating on Apple.

Overview

This UBS Evidence Lab update uses daily iPhone availability data across more than 30 geographies to assess early demand signals for the iPhone 18 Pro models. UBS finds that wait times have improved modestly week on week and are broadly flat year on year outside China, but keeps its iPhone forecasts and Neutral rating unchanged.

Core views

UBS's Apple Availability Study shows that average wait times rose by about three days week on week for the iPhone 18 Pro and by about two days for the iPhone 18 Pro Max. The resulting year-on-year comparisons improved from roughly negative two days in the prior week's initial reading to about negative one day for both models. China is the principal drag: its year-on-year wait-time delta is negative four days. Excluding China, wait times are essentially flat across regions, which UBS says may indicate marginally improving demand trends. The model-level data show an average 24-day wait for the iPhone 18 Pro Max, compared with about 25 days for the iPhone 17 Pro Max and 23 days for the iPhone 16 Pro Max. The iPhone 18 Pro averages about 17 days, versus 18 days for the iPhone 17 Pro and 17 days for the iPhone 16 Pro. In China, the iPhone 18 Pro Max wait is about 21 days, versus 25 days for the 17 Pro Max and 18 days for the 16 Pro Max; the iPhone 18 Pro wait is about 15 days, versus 20 and 14 days, respectively. UBS highlights China availability as an important monitoring item. Prior UBS surveys indicated greater interest in foldable devices, and specifically an Apple foldable, in China than in other markets. Because availability in China was basically unchanged week on week, UBS believes the longer year-on-year waits there may reflect consumers waiting for the expected Duo launch in October. The firm also considers wait times approaching that launch to be important demand datapoints. The availability findings do not change UBS's iPhone forecasts. The firm estimates September-2026-quarter iPhone revenue of US$55.9bn, up 14.0% year on year and consistent with guidance for mid-teens growth, on 55.0m units, up 2.8%. For fiscal 2026, it estimates iPhone revenue of US$252.4bn, up 20.4%, and 261.0m units, up 15.4%. UBS retains a US$296 price target, derived from roughly 29x its blended calendar-2027/calendar-2028 EPS estimate of US$10.31. At that multiple, UBS says Apple would trade about two turns below its trailing-12-month average. The valuation framing recognizes solid iPhone demand, but also increasingly difficult gross-margin headwinds and supply-chain challenges. The report retains a 12-month Neutral rating; the US$296 target compares with a US$340.23 share price on 22 September 2026 and a reported forecast price appreciation of negative 13.0%.

Analysis framework

UBS first tracks daily product availability and wait times across more than 30 geographies, comparing the latest iPhone 18 Pro models both week on week and with prior iPhone generations. It then isolates China to interpret a region-specific demand signal, maintains its iPhone revenue and unit forecasts, and values Apple using a blended forward P/E multiple.

Methodology notes

• Industry AnalysisSupply-demand framework

  iPhone availability and wait-time tracking

  UBS uses daily availability data as an indicator of demand relative to product supply, comparing wait times by model, geography, week and product generation.

• Valuation methodsP/E and PEG Valuation

  Forward P/E valuation

  UBS derives its US$296 price target by applying an approximately 29x multiple to its blended calendar-2027 and calendar-2028 EPS estimate of US$10.31.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Apple Inc. (AAPL.US)

  Primary covered company; iPhone availability trends inform UBS's assessment of near-term demand.

  Strengths

  UBS cites solid iPhone demand and wait times that are broadly flat year on year outside China.

  Weaknesses

  Increasingly difficult gross-margin headwinds and supply-chain challenges.

  Comparison

  The iPhone 18 Pro and Pro Max wait times are compared with the iPhone 17 and iPhone 16 Pro generations across major geographies.

  Risks

  Product delays or less innovative offerings, lower iPhone unit shipments, macro weakness especially in China, weaker differentiation, regulation and poor platform management.

Key data

• iPhone 18 Pro wait-time change~3 days WoW; ~17 days averageAverage wait time rose week on week; about 17 days versus 18 days for iPhone 17 Pro and 17 days for iPhone 16 Pro.
• iPhone 18 Pro Max wait-time change~2 days WoW; ~24 days averageAverage wait time rose week on week; about 24 days versus 25 days for iPhone 17 Pro Max and 23 days for iPhone 16 Pro Max.
• Average year-on-year wait-time delta~ -1 day for both Pro modelsImproved from last week's initial ~ -2-day comparison; China contributed a ~ -4-day delta.
• September-2026-quarter iPhone forecastUS$55.9bn revenue; 55.0m unitsRevenue +14.0% YoY and units +2.8% YoY.
• Fiscal-2026 iPhone forecastUS$252.4bn revenue; 261.0m unitsRevenue +20.4% YoY and units +15.4% YoY.
• ValuationUS$296 target; ~29x blended CY27/CY28 EPS of US$10.31The multiple is roughly two turns below Apple's trailing-12-month average.

Impact & implications

UBS interprets broadly flat year-on-year wait times outside China as a potentially improving marginal demand signal, while treating China as the key uncertainty ahead of the expected October Duo launch. The data do not alter UBS's iPhone estimates or Neutral rating, and its target valuation continues to reflect demand strength alongside margin and supply-chain constraints.

Risks

• Product delays or less innovative offerings could reduce iPhone unit shipments.
• Macro weakness could dampen product demand, especially in China.
• Reduced product differentiation could enable a successful lower-end smartphone challenge.
• Governments could increase regulation as Apple's influence grows.
• Poor platform management is a stated risk to UBS's Apple thesis.

What to watch

• iPhone wait times heading into the expected Duo launch in October.
• China iPhone availability and whether consumer interest shifts toward an Apple foldable.
• Whether wait-time trends outside China continue to support improving marginal demand.